Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960009/S548

Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

Medtronic, Inc. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP960009/S548

What did the FDA decide?

The FDA recorded a 30-Day Notice decision coded OK30 on 2026-10-30 for P960009/S548, a supplement to Medtronic, Inc.'s Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense. The device category is an implanted electrical stimulator for parkinsonian tremor, classified under product code MHY in the Neurology specialty. The supplement reason is a process change affecting manufacturer, sterilizer, packager or supplier.

The recorded scope covers three manufacturing changes: adding a new surface mount technology production line, revising the SMT process sequence so automated optical inspection follows each SMT assembly stage, and adding an equivalent solder paste inspection system plus a qualified de-paneling machine for PCBA production. This action concerns production process and equipment only; it is not an approval of the whole system, and no clinical, efficacy or labeling conclusions follow from the record. The source lists no documents, so inspection criteria, validation data and line qualification details remain unknown.

FDA approval order statement

approval for the following three changes: 1) Adding a new surface mount technology (SMT) production line.2) Revision of the SMT manufacturing process sequence to perform automated optical inspection immediately following each SMT assembly stage.3) Addition of an equivalent solder paste inspection system and addition of a qualified de-paneling machine for PCBA production
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960009/S548
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960009 · Original PMA

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  2. P960009/S546 · Related supplement

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  3. P960009/S548 received

    Application receipt date recorded by FDA.

  4. P960009/S542 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  5. P960009/S547 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)

  6. P960009/S548 · FDA decision

    30-Day Notice

  7. P960009/S545 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)

Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960009

Explore the linked device profile

Other records with product code MHY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records